Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: Implications for HIV prevention

Canadian Journal of Public Health

Volumn 94, Issue 5, 2003, Pages 355-359

  Wood, Evan ^a,b   Spittal, Patricia M ^a,b   Kerr, Thomas ^a,c   Small, Will ^a   Tyndall, Mark W ^a,b   O'Shaughnessy, Michael V ^a,b   Schechter, Martin T ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF VICTORIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIAMORPHINE;

ADULT; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG USE; EPIDEMIC; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; INTERVIEW; INTRAVENOUS DRUG ABUSE; JUGULAR VEIN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PUBLIC HEALTH; REGRESSION ANALYSIS; SELF REPORT; SEROCONVERSION; SEX DIFFERENCE; SYRINGE;

EID: 0142182027     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03403560     Document Type: Article

References (33)

1. Strathdee SA, Patrick DM, Archibald CP, Ofner M, Cornelisse PG, Rekart M, et al. Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Addiction 1997;92:1339-47.
2. Wood E, Schechter MT, Tyndall MW, Montaner JS, O'Shaughnessy MV, Hogg RS. Antiretroviral medication use among injection drug users: Two potential futures. AIDS 2000;14:1229-35.
3. Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, et al. Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS 1997;11:F59-65.
4. The Needle Exchange Programs Prohibition Act of 1998 - Statements on Introduced bills and Joint Resolutions (Senate - April 21, 1998); Congressional Record, 1998;S3356.
5. Bennett SS. Needle-exchange programmes in the USA [letter; comment]. Lancet 1998;351(9105):839.
6. Bellm J. Needle-exchange programmes are not the answer [letter; comment). Lancet 1999;353:1657-61.
7. Wood E, Tyndall MW, Spittal P, Li K, R.S. H, O'Shaughnessy M, et al. Needle exchange and difficulty with needle access during an ongoing HIV epidemic. Int J Drug Policy 2002;13:95-102.
8. Schechter MT, Strathdee SA, Cornelisse PG, Currie S, Patrick DM, Rekart ML, et al. Do needle exchange programmes increase the spread of HIV among injection drug users?: An investigation of the Vancouver outbreak. AIDS 1999;13:F45-51.
9. Tyndall MW, Currie S, Spittal P, Li K, Wood E, O'Shaughnessy MV, et al. Intensive injection cocaine use as a primary risk factor of HIV seroconversion among polydrug users in Vancouver. AIDS 2003;17(6):887-93.
10. Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help? CMAJ 2001;165:405-10.
11. Kerr T, Palepu A. Safe injection facilities in Canada: Is it time? CMAJ 2001;165:436-37.
12. Harm reduction: Closing the distance. CMAJ 2001;165:389, 391.
13. Spittal PM, Craib KJ, Wood E, Laliberte N, Li K, Tyndall MW, et al. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ 2002;166:894-99.
14. Miller CL, Johnston C, Spittal PM, Li K, Laliberte N, Montaner JS, et al. Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology 2002;36:737-42.
15. Wood E, Tyndall MW, Spittal PM, Li K, Anis AH, Hogg RS, et al. Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: Investigation of a massive heroin seizure. CMAJ 2003;168:165-69.
16. Wood E, Tyndall MW, Spittal PM, Li K, Hogg RS, Montaner JS, et al. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS 2002;16:941-43.
17. Spittal PM, Schechter MT. Injection drug use and despair through the lens of gender. CMAJ 2001;164:802-3.
18. Dolan K, Kimber J, Fry C, Fitzgerald J, McDonald D, Frautmann F. Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug and Alcohol Review 2000;19:337-46.
19. de Jong W, Weber U. The professional acceptance of drug use: A closer look at drug consumption rooms in the Netherlands, Germany, and Switzerland. Int J Drug Policy 1999;10:99-108.
20. Ronco C, Spuhler G, Coda P, Schopfer R. Evaluation for alley-rooms I, II, and III in Basel. Soc Prev Med 1996;41:S58-68.
21. Kemmesies U. Final Report: The open drug scene and the safe injection room offers in Frankfurt am Main. 1999.
22. van Beek I, Gilmour S. Preference to have used a medically supervised injecting centre among injecting drug users in Kings Cross, Sydney. Aust N Z J Public Health 2000;24:540-42.
23. Wood E, Kerr T, Spittal PM, Li K, Small W, Tyndall MW, et al. The potential public health and community impacts of safer injecting facilities: Evidence from a cohort of injection drug users. J Acquir Immune Defic Syndr 2003;32:2-8.
24. Kimber J, MacDonald M. Six Month Process Report on the Medically Supervised Injecting Centre. National Alcohol and Drug Research Centre, University of New South Wales, 2002.
25. Broadhead, RS. Kerr, TH. Grund JP, Altice FL. Safer injection facilities in North America: Their place in public policy and health initiatives. J Drug Issues 2002;32(1):329-55.
26. Wood A, Stewart W, Zetel P. Supervising consumption: Exploring the implications for nursing in Canada. Annual Conference of the Canadian Association for Nurses in AIDS Care. Vancouver, BC, 2002.
27. Vancouver Sun, Friday April 12, 2002, A2. Nurses help addicts inject heroin.
28. Vancouver Sun, Saturday April 13, 2002, B6. Nothing illegal at AIDS clinic: police.
29. Malkin I, Gold J, Elliott R. Safe Injection Sites: Issues, Obstacles & Obligations. Montreal: Canadian HIV/AIDS Legal Network, 2002.
30. Elliot R, Malkin I, Gold J. Establishing Safe Injection Facilities in Canada: Legal and Ethical Issues. Canadian HIV/AIDS Legal Network, 2002.
31. De Irala J, Bigelow C, McCusker J, Hindin R, Zheng L. Reliability of self-reported human immunodeficiency virus risk behaviours in a residential drug treatment population. Am J Epidemiol 1996;143:725-32.
32. Des Jarlais DC, Paone D, Milliken J, Turner CF, Miller H, Gribble J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: A quasi-randomised trial. Lancet 1999;353:1657-61.
33. Canadian HIV/AIDS Legal Network. Injection Drug Use and HIV/AIDS: Legal and Ethical Issues. Montreal: Canadian HIV/AIDS Legal Network, 1999.